Vicarious Surgical Inc.
RBOT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $2 | $2 | $0 | $0 |
| Gross Profit | -$2 | -$2 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $40 | $48 | $44 | $22 |
| G&A Expenses | $22 | $27 | $30 | $13 |
| SG&A Expenses | $26 | $33 | $36 | $16 |
| Sales & Mktg Exp. | $5 | $6 | $6 | $3 |
| Other Operating Expenses | -$2 | -$2 | $0 | $0 |
| Operating Expenses | $64 | $79 | $80 | $38 |
| Operating Income | -$67 | -$81 | -$80 | -$38 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3 | $10 | $85 | $3 |
| Pre-Tax Income | -$63 | -$71 | $5 | -$35 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$63 | -$71 | $5 | -$35 |
| % Margin | – | – | – | – |
| EPS | -10.72 | -14.7 | 1.27 | -10.92 |
| % Growth | 27.1% | -1,257.5% | 111.6% | – |
| EPS Diluted | -10.72 | -14.6 | 1.21 | -10.92 |
| Weighted Avg Shares Out | 6 | 5 | 4 | 3 |
| Weighted Avg Shares Out Dil | 6 | 5 | 4 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $4 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $1 | $0 |
| EBITDA | -$61 | -$69 | $6 | -$35 |
| % Margin | – | – | – | – |